| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.06 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.07 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.07 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.068 | 0.07 |